62867-47-4 (（8beta，9beta，10xi）-6,8-二甲基-2-（2-甲基丁-3-烯-2-基）麦角林-9-基乙酸酯,(8beta,9beta,10xi)-6,8-dimethyl-2-(2-methylbut-3-en-2-yl)ergolin-9-yl acetate)

(8beta,9beta,10xi)-6,8-dimethyl-2-(2-methylbut-3-en-2-yl)ergolin-9-yl acetate;[(6aR,9S,10S)-7,9-dimethyl-5-(2-methylbut-3-en-2-yl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-10-yl] acetate;2-(1,1-Dimethyl-2-propenyl)-6,8β-dimethylergolin-9β-ol acetate;[(6Ar,9S,10S)-7,9-dimethyl-5-(2-methylbut-3-en-2-yl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-10-yl] acetate;Q15410968;DTXSID60978599;Fumigaclavine C;62867-47-4;SM-1;(8beta,9beta)-6,8-dimethyl-2-(2-methylbut-3-en-2-yl)ergolin-9-yl acetate;Ergolin-9-ol, 2-(1,1-dimethyl-2-propenyl)-6,8-dimethyl-, acetate (ester), (8-beta,9-beta)-;BRN 0717965;CHEBI:64673;(8S,9S)-Fumigaclavine C;SCHEMBL24925832;

OSICWVVWEXKSBD-LFAYTRTRSA-N

1S/**********/c1-7-23(4,5)22-16-11-18-20(15-9-8-10-17(24-22)19(15)16)21(27-14(3)26)13(2)12-25(18)6/h7-10,13,18,20-21,24H,1,11-12H2,2-6H3/t13-,18+,20+,21-/m0/s1

O(C(C)=O)[C@H]1[C@@H](C)CN(C)[C@@H]2CC3=C(C(C=C)(C)C)NC4=CC=CC(=C34)[C@H]21